IRIS
ROSSI, LUIGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.265
EU - Europa 14.409
AS - Asia 5.933
SA - Sud America 452
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 72
OC - Oceania 38
Totale 37.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.983
NL - Olanda 5.616
GB - Regno Unito 3.169
CN - Cina 2.916
SG - Singapore 1.678
UA - Ucraina 1.269
IT - Italia 1.167
SE - Svezia 742
RU - Federazione Russa 585
FI - Finlandia 540
DE - Germania 522
TR - Turchia 472
BR - Brasile 340
IE - Irlanda 282
FR - Francia 267
VN - Vietnam 205
CA - Canada 159
JP - Giappone 159
IN - India 110
KR - Corea 64
HK - Hong Kong 63
MX - Messico 53
PL - Polonia 51
BD - Bangladesh 45
ES - Italia 41
PK - Pakistan 40
AU - Australia 35
BE - Belgio 34
AR - Argentina 33
ZA - Sudafrica 28
IQ - Iraq 22
CO - Colombia 20
EC - Ecuador 20
ID - Indonesia 19
IR - Iran 18
RO - Romania 18
SA - Arabia Saudita 17
AT - Austria 16
VE - Venezuela 16
LT - Lituania 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
HN - Honduras 13
TG - Togo 13
CL - Cile 12
CR - Costa Rica 12
IL - Israele 11
MA - Marocco 11
PT - Portogallo 10
CH - Svizzera 9
PH - Filippine 9
GT - Guatemala 8
JM - Giamaica 8
KZ - Kazakistan 8
UZ - Uzbekistan 8
EE - Estonia 7
JO - Giordania 7
AZ - Azerbaigian 6
PA - Panama 6
PR - Porto Rico 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
LV - Lettonia 5
NI - Nicaragua 5
NO - Norvegia 5
TN - Tunisia 5
AM - Armenia 4
CW - ???statistics.table.value.countryCode.CW??? 4
GE - Georgia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
BY - Bielorussia 3
EG - Egitto 3
GR - Grecia 3
KE - Kenya 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PE - Perù 3
AL - Albania 2
BG - Bulgaria 2
ET - Etiopia 2
GP - Guadalupe 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
SI - Slovenia 2
SM - San Marino 2
Totale 37.169
Salva come PNG Salva come JPEG
Città #
Amsterdam 5.595
Southend 2.825
Fairfield 1.692
Ashburn 1.590
Woodbridge 1.549
Houston 1.094
Jacksonville 1.012
Ann Arbor 892
Singapore 822
San Jose 762
Chandler 738
Cambridge 653
Seattle 648
Wilmington 582
Nanjing 542
Dallas 426
Beijing 402
Izmir 348
Boardman 292
Dublin 280
Council Bluffs 279
Urbino 255
Helsinki 239
Nanchang 229
New York 211
Los Angeles 190
San Mateo 167
Lauterbourg 160
Princeton 150
Shenyang 125
Hebei 120
Santa Clara 112
Jiaxing 102
Düsseldorf 99
Munich 97
Tianjin 97
Changsha 84
Buffalo 75
Ho Chi Minh City 71
Istanbul 70
San Diego 64
Kunming 62
Mülheim 57
São Paulo 56
Bremen 55
San Francisco 55
Hong Kong 52
Jinan 52
Moscow 52
Shanghai 52
Toronto 52
Seongnam 50
Chicago 49
Orem 49
Tokyo 48
London 46
Guangzhou 45
Hangzhou 43
Rome 43
Zhengzhou 42
Hanoi 41
Atlanta 39
Frankfurt am Main 37
Montreal 37
Brooklyn 35
Poplar 35
Warsaw 33
Brussels 32
Velikiy Novgorod 31
Turku 29
Denver 27
Ningbo 27
Phoenix 27
Chennai 26
Stockholm 24
Ancona 23
Bologna 23
Changchun 23
Des Moines 23
North Bergen 23
Taizhou 21
Johannesburg 19
Milan 19
Mexico City 18
Auburn Hills 17
Paris 17
The Dalles 17
Fano 16
Manchester 16
Portsmouth 16
Redwood City 16
Charlotte 15
Rawalpindi 15
Rimini 15
Shenzhen 15
Ankara 14
Augusta 14
Leawood 14
Nuremberg 14
Querétaro 14
Totale 27.617
Salva come PNG Salva come JPEG
Nome #
Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs 2.049
Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules 2.035
Red blood cells could protect miRNAs from degradation or loss thanks to Argonaute 2 binding 1.945
Reengineering red blood cells for cellular therapeutics and diagnostics 421
A new therapy prevents intellectual disability in mouse with phenylketonuria 355
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment 347
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 304
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 300
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 290
2',3'-Dideoxycytidine induced drug resistance in human cells 283
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 281
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. 280
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 277
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus 274
Improved cellular uptake of functionalized single-walled carbon nanotubes 274
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia 273
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 272
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 266
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy 264
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 263
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T 260
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 259
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes 257
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 256
Drug delivery through phagocytosis of red blood cells 255
Erythrocyte-based drug delivery 254
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 253
Erythrocytes as a controlled drug delivery system: clinical evidences 248
Drug delivery by red blood cells 248
Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean 247
Targeting antiviral nucleotide analogues to macrophages 247
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 245
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 241
Drug delivery systems 241
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 241
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 238
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice 238
Acyclovir prodrug and its use in pharmaceutical compositions 237
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 236
Approaches to erythrocyte-mediated drug delivery 236
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment 235
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes 231
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells 230
Acetaldehyde oxidation by aldehyde dehydrogenase-loaded erythrocytes. 229
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 229
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages 227
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 227
Inhibition of murine AIDS by reduced glutathione. 225
Redox homeostasis as a target for new antimycobacterial agents 224
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 220
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells 215
Use of nonvolatile buffers in liquid chromatography/mass spectrometry: advantages of capillary-scale particle beam interfacing 215
Erythrocyte-mediated delivery of recombinant enzymes 214
Red Blood Cell Membrane Processing for Biomedical Applications 214
Targeting nucleotide dimers containing antiviral nucleosides 213
Acetaldehyde, ethanol and acetone concetrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes. 207
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 207
An ex-vivo erythrocyte model for investigating oxidative metabolism 205
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 203
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study 203
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes 203
Membrane-bound immunoglobulins increase during red blood cell aging. 202
Fine distribution of CLOCK protein in hepatocytes of hibernating dormice. 201
A new homodimer of acyclovir as a prodrug with increased solubility and antiviral activity 200
Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies 198
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 197
Macrophage protection by nucleoside and nucleotide analogue administration 197
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 196
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 195
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 194
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 194
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 193
Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine 191
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 191
Red blood cell phagocytosis following hexokinase inactivation. 191
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 190
Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes 189
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 189
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir 189
Effect of phenylhydrazine on red blood cell metabolism. 189
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 187
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 186
Modulated red blood cell survival by membrane protein clustering 185
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activity 184
Improved metabolic properties of hexokinase-overloaded human erythrocytes 184
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 182
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study 180
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 180
Effect of age on some properties of mice erythrocytes 180
In vitro and in vivo methanol degradation by alcohol oxidase-loaded erythrocytes 180
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 179
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 178
Preclinical developments of enzyme-loaded red blood cells 178
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 177
Synthesis, caracterization and erythrocyte encapsulation of an azidothymidine homodinucleotide 177
Preparation of glutathione derivatives as antiviral agents 177
Red Blood Cell Loading: a Selection of Procedures 175
Red blood cells as an antigen-delivery system. 174
Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease 174
Erythrocytes as pharmacological carriers for corticosteroids and other drugs in patients with inflammatory bowel diseases 174
Totale 27.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.224 0 0 0 219 69 59 66 95 124 119 32 441
2022/20232.447 300 107 40 242 246 527 7 174 433 121 160 90
2023/2024697 77 72 47 89 56 143 21 26 8 87 7 64
2024/20252.731 137 132 593 184 81 188 278 154 284 197 255 248
2025/202611.950 586 598 678 1.053 635 391 881 217 5.958 520 323 110
2026/20271.471 174 149 606 542 0 0 0 0 0 0 0 0
Totale 37.512